The microbiology of community-acquired peritonitis in children

Pediatric Infectious Disease Journal

Volumn 30, Issue 2, 2011, Pages 131-135

  Dumont, Romain ^a   Cinotti, Raphaël ^a   Lejus, Corinne ^a   Caillon, Jocelyne ^a,b   Boutoille, David ^a   Roquilly, Antoine ^a   Podevin, Guillaume ^a   Gras Le Guen, Christelle ^a,b   Asehnoune, Karim ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

antibiotic susceptibility; children; pediatric; peritonitis

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; CHILD; CLINICAL EVALUATION; COMMUNITY ACQUIRED PERITONITIS; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUSOBACTERIUM; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; PERITONITIS; POSTOPERATIVE ANALGESIA; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STREPTOCOCCUS;

EID: 79551580346     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181eed7a4     Document Type: Article

References (25)

1. Johnson CC, Baldessarre J, Levison ME. Peritonitis: update on pathophys-iology, clinical manifestations, and management. Clin Infect Dis. 1997;24: 1035-1045; quiz 1046-1047.
2. Montravers P, Lepape A, Dubreuil L, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009;63:785-794.
3. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133-164.
4. Lin WJ, Lo WT, Chu CC, et al. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children. J Microbiol Immunol Infect. 2006;39:249-254.
5. Decousser JW, Lamy B, Pina P, et al. Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007. Diagn Microbiol Infect Dis. 2010;66:292-300.
6. Andersson RE, Petzold MG. Nonsurgical treatment of appendiceal abscess or phlegmon: a systematic review and meta-analysis. Ann Surg. 2007;246: 741-748.
7. Murray PR. Processing and interpretation of sterile body fluids. Vol 1. Manual of Clinical Microbiology, 6th ed. Washington, DC: ASM Press; 1995.
8. Seguin P, Laviolle B, Chanavaz C, et al. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect. 2006;12:980-985.
9. Management of community-acquired peritonitis. Long text [in French]. Ann Fr Anesth Reanim 2001; 20 (SUPPL. 2):350s-367s.
10. Emil S, Duong S. Antibiotic therapy and interval appendectomy for perforated appendicitis in children: a selective approach. Am Surg. 2007;73:917-922.
11. Bennion RS, Baron EJ, Thompson JE Jr, et al. The bacteriology of gangrenous and perforated appendicitis- revisited. Ann Surg. 1990;211:165-171.
12. Brook I. Bacterial studies of peritoneal cavity and postoperative surgical wound drainage following perforated appendix in children. Ann Surg. 1980;192:208-212.
13. Brook I. Microbiology and management of intra-abdominal infections in children. Pediatr Int. 2003;45:123-129.
14. Brook I. Intra-abdominal, retroperitoneal, and visceral abscesses in children. Eur J Pediatr Surg. 2004;14:265-273.
15. Solomkin JS, Wilson SE, Christou NV, et al. Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg. 2001;233:79-87.
16. Bertrand X, Costa Y, Pina P. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003.] Med Mal Infect. 2005;35:329-334.
17. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 2000;19: 112-117.
18. Lau SM, Peng MY, Chang FY. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect. 2004;37:185-191.
19. Ito Y, Kato N, Kato H, et al. Bacteriological study of 28 patients with intraabdominal infection in Japan. J Infect Chemother. 2000;6:168-172.
20. Teng LJ, Hsueh PR, Tsai JC, et al. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob Agents Chemother. 2002;46:2908-2913.
21. Yellin AE, Heseltine PN, Berne TV, et al. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet. 1985;161:303-307.
22. Aronoff SC, Olson MM, Gauderer MW, et al. Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis. J Pediatr Surg. 1987;22:861-864.
23. Kaplan S. Antibiotic usage in appendicitis in children. Pediatr Infect Dis J. 1998;17:1047-1048.
24. Krobot K, Yin D, Zhang Q, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004;23:682-687.
25. Bartlett JG. Experimental aspects of intraabdominal abscess. Am J Med. 1984;76:91-98.